Ambroxol (Mucosolvan)

163  relevant articles (18 outcomes, 32 trials/studies) found for this Bio-Agent

Mucosolvan; 4-(((2-Amino-3,5-dibromophenyl)methyl)amino)cyclohexanol; AMBROPP; Abrohexal; Ambril; Ambro-Puren; Ambrobeta; Ambrofur; Ambrohexal; Ambrolitic; Ambrolös; Ambroten; Ambroxin; Ambroxocompren; Berlin-Chemie Brand of Abmbroxol Hydrochloride; Betapharm Brand of Ambroxol Hydrochloride; Bisolvon AM; Boehringer Ingelheim Brand of Ambroxol Hydrochloride; Bronchopront; Bronchowern; Broxol; Carnot Brand of Ambroxol Hydrochloride; Cascan Brand of Ambroxol Hydrochloride; Chiesi Brand of Ambroxol Hydrochloride; Contac Husten-Trunk; Degort's Brand of Ambroxol Hydrochloride; Diba Brand of Ambroxol Hydrochloride; Dinobroxol; Duramucal; Ebromin; Esparma Brand of Ambroxol Hydrochloride; Europharma Brand of Ambroxol Hydrochloride; Expeflen; Expit; Farmabroxol; Farmasan Brand of Ambroxol Hydrochloride; Flavamed; Frenopect; Fustery Brand of Ambroxol Hydrochloride; Gelopol; Glaxo Wellcome Brand of Ambroxol Hydrochloride; Hefa Brand of Ambroxol Hydrochloride; Hexal Brand of Ambroxol Hydrochloride; Isis Brand of Ambroxol Hydrochloride; Larylin Husten-Löser; Lasolvan; Lichtenstein Brand of Ambroxol Hydrochloride; Mack Brand of Ambroxol Hydrochloride; Marjan Brand of Ambroxol; Merck Brand of Ambroxol Hydrochloride; Mibrox; Motosol; Muco-Fips; Mucotablin; NA-872; Nattermann Brand of Ambroxol Hydrochloride; Orion Brand of Ambroxol Hydrochloride; Pect Hustenlöser; Promeco Brand of Ambroxol Hydrochloride; Pulmonal S; Pulmopharm Brand of Ambroxol Hydrochloride; Pädia Brand of Ambroxol; Pädiamuc; Rentschler Brand of Ambroxol Hydrochloride; Ringelheimer Pulmonal; Sankyo Brand of Ambroxol Hydrochloride; Schaper & Brümmer Brand of Ambroxol Hydrochloride; Sekretovit; SmithKline Beecham Brand of Ambroxol Hydrochloride; Stada Brand of Ambroxol Hydrochloride; Surbronc; Teva Brand of Ambroxol Hydrochloride; Therapin Hustenlöser; Thomae Brand of Ambroxol Hydrochloride; Wernigerode Brand of Ambroxol Hydrochloride; stas-Hustenlöser; AM, Bisolvon; Ambro Puren; AmbroPuren; Ambroxol Marjan Brand; Ambroxol Pädia Brand; Berlin Chemie Brand of Abmbroxol Hydrochloride; Contac Husten Trunk; Contac HustenTrunk; Hustenlöser, Pect; Hustenlöser, Therapin; Larylin Husten Löser; Larylin HustenLöser; Metabolite VIII, Bromhexine; Muco Fips; MucoFips; NA 872; NA872; Pulmonal, Ringelheimer; stas Hustenlöser; stasHustenlöser; Bromhexine Metabolite VIII; Cyclohexanol, 4-(((2-amino-3,5-dibromophenyl)methyl)amino)-, trans-

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Gillissen, Adrian: 2 articles (11/2005 - 01/2002)
2.	Pschorn, Uwe: 2 articles (01/2002 - 01/2002)
3.	Peil, Hubertus: 2 articles (01/2002 - 01/2002)
4.	Aicher, Bernhard: 2 articles (01/2002 - 01/2002)
5.	Müller, Achim: 2 articles (01/2002 - 01/2002)
6.	de Mey, Christian: 2 articles (01/2002 - 01/2002)
7.	Dai, Hong-song: 1 article (09/2007)
8.	Bachet, P: 1 article (10/2006)
9.	Giannoli, C: 1 article (10/2006)
10.	Vial, T: 1 article (10/2006)

Related Diseases

1.	Syndrome 09/22/1977 - "[Prevention and therapy of respiratory distress syndrome in premature infants by means of bromhexine metabolite VIII. Animal experimental studies on the therapeutic efficacy of bromhexine metabolite VIII in premature respiratory distress syndrome]" 05/01/1997 - "CONCLUSION: This study does not suggest the efficacy of antenatal ambroxol treatment both for the prevention of neonatal respiratory distress syndrome and for the reduction of its severity." 09/01/2009 - "[Efficacy of different dosages of ambroxol hydrochloride in the prevention of neonatal respiratory distress syndrome.]" 08/01/2006 - "[Efficacy of intravenous or atomizing ambroxol for prevention of respiratory distress syndrome in preterm infants]" 05/01/1992 - "In order to test the ability of Ambroxol to improve the clinical course of respiratory distress syndrome and to reduce the incidence of complications a multicentre, randomized, placebo-controlled double-blind trial was conducted. " Order ALL the reference details at left...
2.	Cough 01/01/1986 - "However, remission of the cough, of the chest pathological signs, as well as the improvement of the lung radiographical pictures were significantly more rapid in children treated with ambroxol than in those who received the antibiotic alone. " 09/01/2006 - "OBJECTIVE: This study was designed to evaluate the "real life" behavior of consumers with non-prescription access to an ambroxol cough syrup with special focus on tolerability and the pattern of product usage. " 02/01/1998 - "CONCLUSION: The study suggests, that ambroxol has a cough-suppressive effect. " 02/01/1998 - "METHODS: In the present study, the effects of ambroxol on the cough reflex in the cats were investigated. " 01/01/1987 - "The first trial involving 60 patients daily treated with 120 mg of ambroxol showed significant differences (p less than 0.05) in sputum volume, sputum viscosity, difficulty of expectoration, and severity of cough when compared with the placebo group. " Order ALL the reference details at left...
3.	Chronic Bronchitis 01/01/1985 - "Ambroxol has previously been shown to change the airway secretions of patients affected by chronic bronchitis; these secretions significantly improved mucociliary transport when applied to the frog palate. " 01/01/1996 - "This study was designed to examine the efficacy and tolerability of ambroxol (Ambrosol) on the symptomatology of chronic bronchitis among in- and out-patients. " 10/01/1995 - "To verify the possibility of producing anti-inflammatory effects in a clinically relevant condition, 20 patients with chronic bronchitis, randomly divided into two balanced matched groups, were submitted to a 14 day trial with Ambroxol, 150 mg.day-1, or placebo, according to a double-blind design. " 10/01/1987 - "A controlled trial of ambroxol in chronic bronchitis." 03/01/1987 - "Fourteen subjects with simple chronic bronchitis, who belonged to a "responder" group in an earlier study on the subjective effects of ambroxol, were examined using a double-blind cross-over design comparing 120 mg ambroxol daily and placebo. " Order ALL the reference details at left...
4.	Pain (Aches) 12/01/2005 - "Ambroxol (1g/kg) was only weakly effective in models for acute pain, but effectively reduced pain symptoms in all other models; in some cases it completely reversed pain behaviour. " 01/01/2002 - "RESULTS: All treatments led to a reduction of pain intensity; the means (+/- SD) SPIDnorm after the 1st lozenge were 0.53 +/- 0.28 or 0.50 +/- 0.30 or 0.38 +/- 0.28 with 20 mg or 30 mg ambroxol hydrochloride or placebo respectively in study I, and 0.53 +/- 0.30 or 0.60 +/- 0.28 or 0.39 +/- 0.31 in study II; the effect of treatment was statistically significant (p: 0.0002 or p: 0.0033 in study I and p: 0.0005 or p: 0.0001 in study II, respectively, for the comparison of 20 mg or 30 mg ambroxol hydrochloride vs. placebo). " 01/01/2008 - "Detailed investigations of ambroxol with modern pharmacological methods yielded additional interesting results: ambroxol has been found to have profound effects on neuronal voltage-gated Na(+), as well as Ca(2+) channels, and to effectively reduce chronic inflammatory and neuropathic pain in rodents. " 12/01/2005 - "Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain." 01/01/2002 - "RESULTS: Both treatments led to a reduction of pain intensity; the mean (+/- SD) SPIDnorm after the 1st lozenge were 0.39 +/- 0.27 and 0.28 +/- 0.25 for 20 mg ambroxol hydrochloride and placebo, respectively; the treatment effect of ambroxol was statistically significantly superior compared to placebo (p: 0.0029; 95% confidence interval estimate of the mean treatment difference for ambroxol minus placebo: 0.04 to 0.18). " Order ALL the reference details at left...
5.	Pharyngitis (Sore Throat) 01/01/2008 - "Presently, the evidence from randomised, placebo-controlled, double-blind clinical trials (RCT) with the local anaesthetic ambroxol (CAS 23828-92-4) in the treatment of sore throat is being reviewed. " 01/01/2008 - "It is concluded that lozenges containing 20 mg ambroxol are a safe and efficacious treatment for acute uncomplicated sore throat of recent onset in adult patients." 01/01/2008 - "Efficacy and safety of ambroxol lozenges in the treatment of acute uncomplicated sore throat. " 01/01/2008 - "In 2002, ambroxol lozenges were marketed for the treatment of sore throat making use of its local anesthetic effect. " 01/01/2002 - "Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Cyclohexanols
2.	Acetylcysteine (Siran)
3.	Methacholine Chloride (Methacholine)
4.	Carbocysteine (S-Carboxymethylcysteine)
5.	Placebos
6.	Amoxicillin (Wymox)
7.	ditec
8.	Ambroxol (Mucosolvan)
9.	Steroids
10.	Betamethasone (Celestone)

Related Therapies and Procedures

1.	Artificial Respiration (Mechanical Ventilation)
2.	Intravenous Infusions
3.	Aftercare (After-Treatment)
4.	Oral Administration
5.	Transplants (Transplant)